Skip to main
  1. Stocks
  2. Tempus AI Inc
  3. Forecast
TEM

TEM Stock Forecast & Price Target

TEM Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 32%
Buy 26%
Hold 42%
Sell 0%
Strong Sell 0%

Bulls say

Tempus AI is supported by a powerful combination of accelerating oncology diagnostics, a fast-growing data platform, and a widening AI-enabled moat, with 3Q26 revenue of $411.5M rising 23.1% YoY and full-year FY2026 revenue guided to $1,600-1,605M. Its fundamentals are strengthened by 32% YoY oncology testing growth, 33% YoY data and applications growth, record data-licensing bookings above $550M year-to-date, and improving profitability, as adjusted EBITDA reached $25.6M while FY2026 EBITDA guidance was maintained at about $65M. The company also has multiple self-funding growth catalysts, including xT CDx pricing migration, xF and MRD reimbursement upside, and the planned Personalis acquisition, which should deepen revenue visibility and expand exposure to a larger MRD market.

Bears say

Tempus AI is facing a negative fundamental setup because its diagnostics business appears exposed to execution and focus risks tied to its commercial partner, while its revenue visibility is weakened by highly variable pharma ordering patterns and budgets that can shift quarter-to-quarter as priorities change. The company also faces uncertainty around ordering frequency and funding from the U.S. Department of Veterans Affairs for the Million Veteran Program, adding another layer of instability to demand and near-term operating performance. In addition, the possibility that Tempus’s deal to acquire PSNL might not close could force PSNL to increase spending and investment, which would underscore capital intensity and integration risk rather than durable fundamental strength.

TEM has been analyzed by 19 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 26% recommend Buy, 42% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.

TEM Analyst Forecast & Price Prediction

Get the latest TEM stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in TEM

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tempus AI Inc (TEM) Forecast

Analysts have given TEM a Buy based on their latest research and market trends.

According to 19 analysts, TEM has a Buy consensus rating as of Nov 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $79.84, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $79.84, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tempus AI Inc (TEM)


TEM Analyst Forecast & Price Prediction

Get the latest TEM stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in TEM

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover TEM stock data and trends